Covered recipient · General Payments record
SARAH H LEWIS
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2023–2024
$667.29
- Reported across 38 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $523.43 | 30 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $180.75 | 11 |
| PFIZER INC. | $107.46 | 6 |
| Lilly USA, LLC | $87.06 | 5 |
| Abbott Laboratories | $69.29 | 3 |
| Novo Nordisk AS | $32.01 | 2 |
| Janssen Pharmaceuticals, Inc | $16.67 | 1 |
| Exact Sciences Corporation | $15.12 | 1 |
| Acerta Pharma LLC | $15.07 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (30)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $22.03 | 07/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125294846 | CMS |
| Abbott Laboratories | $24.40 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125294848 | CMS |
| Abbott Laboratories | $22.86 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125294850 | CMS |
| ABBVIE INC. | $6.39 | 01/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104170636 | CMS |
| ABBVIE INC. | $22.27 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104170638 | CMS |
| ABBVIE INC. | $28.97 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104170640 | CMS |
| ABBVIE INC. | $23.98 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104170642 | CMS |
| ABBVIE INC. | $26.96 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104170644 | CMS |
| ABBVIE INC. | $6.73 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104170646 | CMS |
| ABBVIE INC. | $14.80 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104170648 | CMS |
| ABBVIE INC. | $3.04 | 07/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104170650 | CMS |
| ABBVIE INC. | $21.64 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104170652 | CMS |
| ABBVIE INC. | $24.79 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104170654 | CMS |
| ABBVIE INC. | $1.18 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104170656 | CMS |
| AstraZeneca Pharmaceuticals LP | $15.07 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104495448 | CMS |
| Exact Sciences Corporation | $15.12 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114756460 | CMS |
| Janssen Pharmaceuticals, Inc | $16.67 | 03/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078223135 | CMS |
| Lilly USA, LLC | $17.59 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135366566 | CMS |
| Lilly USA, LLC | $20.05 | 07/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135395229 | CMS |
| Lilly USA, LLC | $14.78 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135392299 | CMS |
| Lilly USA, LLC | $19.88 | 11/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135417635 | CMS |
| Lilly USA, LLC | $14.76 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135366568 | CMS |
| Novo Nordisk Inc | $17.73 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096882385 | CMS |
| Novo Nordisk Inc | $14.28 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097295241 | CMS |
| PFIZER INC. | $15.76 | 01/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131128736 | CMS |
| PFIZER INC. | $22.12 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131249120 | CMS |
| PFIZER INC. | $16.49 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131223562 | CMS |
| PFIZER INC. | $20.96 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131439104 | CMS |
| PFIZER INC. | $16.63 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131604598 | CMS |
| PFIZER INC. | $15.50 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131101509 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2023, 2024
- Source files
- Dataset page · Bulk file · PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.